Sarepta Therapeutics (NASDAQ: SRPT) is gaining early Wednesday (+9.5%) after announced the appointment of Edward Kaye, M.D., the company's Chief ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE